Compounds > cycloartane
Page last updated: 2024-09-04

cycloartane and Triple Negative Breast Neoplasms

cycloartane has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Kong, Y; Li, F; Nian, Y; Qiu, MH; Yang, R; Zhou, Z1

Other Studies

1 other study(ies) available for cycloartane and Triple Negative Breast Neoplasms

ArticleYear
KHF16 is a Leading Structure from Cimicifuga foetida that Suppresses Breast Cancer Partially by Inhibiting the NF-κB Signaling Pathway.
    Theranostics, 2016, Volume: 6, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cimicifuga; Humans; NF-kappa B; Phytochemicals; Plant Extracts; Signal Transduction; Triple Negative Breast Neoplasms; Triterpenes

2016